BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36037157)

  • 1. Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.
    Przybyła W; Gjersvoll Paulsen KM; Mishra CK; Nygård S; Engebretsen S; Ruud E; Trøen G; Beiske K; Baumbusch LO
    PLoS One; 2022; 17(8):e0273280. PubMed ID: 36037157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.
    Chicard M; Colmet-Daage L; Clement N; Danzon A; Bohec M; Bernard V; Baulande S; Bellini A; Deveau P; Pierron G; Lapouble E; Janoueix-Lerosey I; Peuchmaur M; Corradini N; Defachelles AS; Valteau-Couanet D; Michon J; Combaret V; Delattre O; Schleiermacher G
    Clin Cancer Res; 2018 Feb; 24(4):939-949. PubMed ID: 29191970
    [No Abstract]   [Full Text] [Related]  

  • 3. Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations.
    Rybinski B; Wolinsky T; Brohl A; Moerdler S; Reed DR; Ewart M; Weiser D
    Genes Chromosomes Cancer; 2020 Feb; 59(2):119-124. PubMed ID: 31515834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing in recurrent early pregnancy loss.
    Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
    Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors.
    Miller AL; Garcia PL; Pressey JG; Beierle EA; Kelly DR; Crossman DK; Council LN; Daniel R; Watts RG; Cramer SL; Yoon KJ
    Sci Rep; 2017 Dec; 7(1):17787. PubMed ID: 29259192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational dynamics between primary and relapse neuroblastomas.
    Schramm A; Köster J; Assenov Y; Althoff K; Peifer M; Mahlow E; Odersky A; Beisser D; Ernst C; Henssen AG; Stephan H; Schröder C; Heukamp L; Engesser A; Kahlert Y; Theissen J; Hero B; Roels F; Altmüller J; Nürnberg P; Astrahantseff K; Gloeckner C; De Preter K; Plass C; Lee S; Lode HN; Henrich KO; Gartlgruber M; Speleman F; Schmezer P; Westermann F; Rahmann S; Fischer M; Eggert A; Schulte JH
    Nat Genet; 2015 Aug; 47(8):872-7. PubMed ID: 26121086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
    Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
    Oncogene; 2003 Apr; 22(15):2343-51. PubMed ID: 12700669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
    Fransson S; Martinez-Monleon A; Johansson M; Sjöberg RM; Björklund C; Ljungman G; Ek T; Kogner P; Martinsson T
    Sci Rep; 2020 Dec; 10(1):22432. PubMed ID: 33384420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome.
    Duijkers FAM; Gaal J; Meijerink JPP; Admiraal P; Pieters R; de Krijger RR; van Noesel MM
    Am J Pathol; 2012 Mar; 180(3):1223-1231. PubMed ID: 22203052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.
    Bestetti I; Barbieri C; Sironi A; Specchia V; Yatsenko SA; De Donno MD; Caslini C; Gentilini D; Crippa M; Larizza L; Marozzi A; Rajkovic A; Toniolo D; Bozzetti MP; Finelli P
    Hum Reprod; 2021 Oct; 36(11):2975-2991. PubMed ID: 34480478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies new somatic alterations and mutation patterns of tongue squamous cell carcinoma in a Chinese population.
    Zhang H; Song Y; Du Z; Li X; Zhang J; Chen S; Chen F; Li T; Zhan Q
    J Pathol; 2020 Aug; 251(4):353-364. PubMed ID: 32432340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
    Altun Z; Yuan H; Baran B; Aktaş S; Sönmez EE; Küçük C; Olgun N
    Gene; 2023 Apr; 860():147233. PubMed ID: 36736507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.
    Degli Esposti C; Iadarola B; Maestri S; Beltrami C; Lavezzari D; Morini M; De Marco P; Erminio G; Garaventa A; Zara F; Delledonne M; Ognibene M; Pezzolo A
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise.
    Landstrom AP; Fernandez E; Rosenfeld JA; Yang Y; Dailey-Schwartz AL; Miyake CY; Allen HD; Penny DJ; Kim JJ
    Heart Rhythm; 2018 Jul; 15(7):1042-1050. PubMed ID: 29501670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK amplification and protein expression predict inferior prognosis in neuroblastomas.
    Wang M; Zhou C; Sun Q; Cai R; Li Y; Wang D; Gong L
    Exp Mol Pathol; 2013 Oct; 95(2):124-30. PubMed ID: 23797004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets.
    Lyu J; Song Z; Chen J; Shepard MJ; Song H; Ren G; Li Z; Guo W; Zhuang Z; Shi Y
    J Pathol; 2018 Mar; 244(3):358-366. PubMed ID: 29230811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
    Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
    Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.
    Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY
    BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
    Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
    Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing identifies novel somatic variants in African American esophageal squamous cell carcinoma.
    Erkizan HV; Sukhadia S; Natarajan TG; Marino G; Notario V; Lichy JH; Wadleigh RG
    Sci Rep; 2021 Jul; 11(1):14814. PubMed ID: 34285259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.